MAPT and Cognitive impairment: A study on the effects of sevoflurane on young mice comparing wild type and Tau-KO showed that sevoflurane increased activation of glycogen synthase kinase 3β (the kinase that is related to Tau phosphorylation) in young WT resulting in cognitive impairment but not in the Tau-KO [46].